Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
GXV-001 by GEXVal for Angelman Syndrome: Likelihood of Approval
GXV-001 is under clinical development by GEXVal and currently in Phase I for Angelman Syndrome. According to GlobalData, Phase I...